Variety of qualified patients: CDEC mentioned the uncertainty in the volume of clients with reasonably extreme to serious hemophilia B in Canada qualified for etranacogene dezaparvovec. Clinical authorities consulted by CADTH indicated that some patients who're classified as obtaining delicate or reasonable sickness may have a extreme bleeding phenotype, which https://baltasark912hik6.wikiexcerpt.com/user